Ignite Creation Date:
2024-05-06 @ 4:14 PM
Last Modification Date:
2024-10-26 @ 2:06 PM
Study NCT ID:
NCT04921527
Status:
RECRUITING
Last Update Posted:
2023-08-31
First Post:
2021-06-03
Brief Title:
Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer
Sponsor:
Chipscreen Biosciences Ltd
Organization:
Chipscreen Biosciences Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Paclitaxel |
| Ovarian Cancer |
| Relapsed or Refractory |
| Chiauranib |
Keywords: